Gattermann N.; Finelli C.; Della Porta M.; Fenaux P.; Ganser A.; Guerci-Bresler A.; Schmid M.; Taylor K.; Vassilieff D.; Habr D.; Domokos G.; Roubert B.; Rose C.; Agaoglu L.; Alimena G.; Alonso D.; Ame S.; Angelucci E.; Arrizabalaga B.; Athanasiou-Metaxa
(, 2010)
The prospective 1-year EPIC study enrolled 341 patients with myelodysplastic syndromes (MDS); although baseline iron burden was 2500. ng-mL, ∼50percent were chelation-naïve. Overall median serum ferritin decreased significantly ...